Jeff Hill

Jeff joined Circassia on 29 January 2018. He brings a broad professional experience that includes marketing, sales, business operations, and technology to Circassia. He has extensive experience in the life sciences industry, including over ten pharmaceutical and medical device product launches throughout his career. Before Circassia, Jeff held various commercial leadership roles, including at an anti-infective start-up Cempra Pharmaceuticals and a gastroenterology-focused Salix Pharmaceuticals. At Salix, he was part of the Marketing Leadership, promoting 15 marketed products before its sale to Valeant for $14.5 billion in 2015. Additionally, Jeff acquired his respiratory experience and passion working with Teva Pharmaceuticals.